Press release
Cancer Biomarkers Market Projected to Reach USD 69.05 Billion by 2034, Growing at a CAGR of 11.2% 4o
Polaris Market Research analyses that the cancer biomarkers market is expected to register a CAGR of 11.2% during the forecast period of 2025 to 2034. The market was valued at USD 23.91 billion in 2024 and is expected to reach USD 69.05 billion by 2034.
Get Exclusive Sample Pages of This Report:https://www.polarismarketresearch.com/industry-analysis/cancer-biomarkers-market/request-for-sample
Market Overview
Cancer biomarkers are genes, proteins, or other substances that can be analyzed to reveal crucial details about an individual's cancer. There are several known cancer biomarkers, and new ones are being detected all the time. Biomarkers typically distinguish a patient with cancer from one without the disease. The changes can result from a number of factors, including germline or somatic mutations, transcriptional changes, and post‐translational modifications. There is a wide range of biomarkers that involve protein, nucleic acid, antibodies, and peptides, amongst other groupings. Biomarkers can also represent a combination of changes, such as gene expression, proteomic profiles, and metabolomic signatures.
Key Drivers
Growing Global Prevalence of Cancer: The growing global prevalence of cancer is a notable driver of the rising need for cancer biomarkers. As per the World Health Organization (WHO), cancer is one of the spearheading causes of death globally, with an approximated 19.3 million contemporary cases and 10 million terminations in 2020, driving the cancer biomarkers market demand.
Technological Advancements: Technological progressions in genomics, proteomics, and metabolomics are pushing the advancement of modern cancer biomarkers. Next-generation sequencing (NGS) and high-throughput screening technologies have transformed the procedure of biomarker detection, enabling the identification of new biomarkers with enhanced accuracy and speed. For instance, the combination of NGS in cancer diagnostics permits panoramic genomic profiling, which assists in recognizing applicable mutations and customized targeted therapies.
Request for a Discount on this Report Before Purchase:https://www.polarismarketresearch.com/industry-analysis/cancer-biomarkers-market/request-for-discount-pricing
Competitive Landscape
The prominent players have adopted strategies such as new product releases, technology advancements, and strategic partnerships to augment their stronghold and increase their customer base. Major companies in the market are noted below:
Abbott Laboratories
Agilent Technologies
Becton, Dickinson and Company
Bio-Rad Laboratories
Exact Sciences Corporation
Genomic Health, Inc. (part of Exact Sciences)
Guardant Health, Inc.
Hologic, Inc.
Illumina, Inc.
Myriad Genetics, Inc.
PerkinElmer, Inc.
Qiagen N.V.
Roche Diagnostics
Siemens Healthineers
Thermo Fisher Scientific
Segmentation Insights
Cancer Biomarkers Market, Type Outlook (Revenue - USD Billion, 2020-2034)
• Breast cancer
• Prostate cancer
• Colorectal cancer
• Cervical cancer
• Liver cancer
• Lung cancer
• Others
Cancer Biomarkers Market, Application Outlook (Revenue - USD Billion, 2020-2034)
• Drug discovery and Development
• Diagnostics
• Personalized medicine
• Others
Cancer Biomarkers Market, Biomolecule Outlook (Revenue - USD Billion, 2020-2034)
• Genetic Biomarkers
• Epigenetic Biomarkers
• Metabolic Biomarkers
• Proteomic Biomarkers
• Others
Explore The Complete Comprehensive Report Here:https://www.polarismarketresearch.com/industry-analysis/cancer-biomarkers-market
Regional Analysis
Key regions studied are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
North America dominates the cancer biomarkers market due to the region's progressive healthcare framework, notable funding in cancer research, and the existence of prominent pharmaceutical and biotechnology firms.
Asia Pacific is the fastest-growing market worldwide. The region's growth is credited to the growing prevalence of cancer, heightened awareness of healthcare infrastructure, and growing recognition of early cancer detection. Nations such as China, Japan, and India are at the forefront with notable government funding in healthcare and biotechnology.
More Trending Latest Reports by Polaris Market Research:
Flat Glass Market https://www.polarismarketresearch.com/industry-analysis/flat-glass-market
Digital Health Market https://www.polarismarketresearch.com/industry-analysis/digital-health-market
Video Conferencing Market https://www.polarismarketresearch.com/industry-analysis/video-conferencing-market
Cryptocurrency Market https://www.polarismarketresearch.com/industry-analysis/cryptocurrency-market
Customer Relationship Management Market https://www.polarismarketresearch.com/industry-analysis/customer-relationship-management-market
Medical Aesthetics Market https://www.polarismarketresearch.com/industry-analysis/medical-aesthetics-market
Medical Devices Market https://www.polarismarketresearch.com/industry-analysis/medical-devices-market
Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Biomarkers Market Projected to Reach USD 69.05 Billion by 2034, Growing at a CAGR of 11.2% 4o here
News-ID: 3955317 • Views: …
More Releases from Polaris Market Research & Consulting
Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of …
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors.
Market at a Glance
In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. It…
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 …
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 3.82 billion in 2024 and is expected to…
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin …
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billion…
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 …
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 31.67 billion in 2024 and is expected to reach…
More Releases for Biomarkers
Biomarkers Market Soars: Safety Biomarkers Lead with 15.9% Projected Growth from …
The global biomarkers market size was valued at US$ 59.1 Billion in 2021 and is expected to expand at a compound annual growth rate CAGR of 15.3% from 2022 to 2032. Safety Biomarkers are expected to be the highest revenue generating biomarker type, with a projected growth of 15.9% from 2022-2032.
Biomarkers, or biological indicators, have revolutionized the fields of medicine and healthcare by enabling early disease detection, personalized treatment, and…
Neurological Biomarkers Market - Decoding Brain Health: Biomarkers Revolutionizi …
Newark, New Castle, USA: The "Neurological Biomarkers Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Neurological Biomarkers Market: https://www.growthplusreports.com/report/neurological-biomarkers-market/8040
This latest report researches the industry structure, sales, revenue,…
Cardiac Biomarkers Market - Unveiling Heart Health: Biomarkers Revolutionizing C …
Newark, New Castle, USA: The "Cardiac Biomarkers Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cardiac Biomarkers Market: https://www.growthplusreports.com/report/cardiac-biomarkers-market/8024
This latest report researches the industry structure, sales, revenue,…
Global Companion Diagnostic Cancer Biomarkers Market by types (Protein Biomarker …
Global Companion Diagnostic Cancer Biomarkers Market Research Report” Purchase This Report by calling ResearchnReports.com at +1-888-631-6977.
The report, titled Companion Diagnostic Cancer Biomarkers presents an in-depth study of the Companion Diagnostic Cancer Biomarkers market. Providing a brief history about the market, the report analyses the entire value chain of the market and points out the key drivers and restraints affecting the growth of the market during the forecast period. The report…
Global Biomarkers Market Propelled by Growing Usage of Biomarkers in Medical Are …
A biomarker refers to a biological molecule or gene that is used to effectively and accurately evaluate pharmacologic responses, pathogenic procedures, and biological procedures. Also known as a molecular marker or signature molecule, biomarkers are found in blood, other body fluids, and tissue. Extensively used to see the body’s response to a particular treatment for a disease or condition, biomarkers assist medical professionals to take effective clinical decisions and help…
Biomarkers Summit
SMi present their 4th annual conference on
Biomarkers Summit
Monday 31st January & Tuesday 1st February 2011
Crowne Plaza The-City, London, UK
Don’t Miss Out - Visit to register your place today
http://www.smi-online.co.uk/preclinical-biomarkers.asp
Sponsored by
Caprotec
Cell Signalling Technology
GVK Bio
Selventa
Millipore Quest Diagnostics
RBM
SMi’s highly anticipated 4th annual Biomarkers Summit is fast approaching, and time is running out…
